By Daniella Parra Swiss life sciences company Lunaphore Technologies SA has agreed to be acquired by Bio-Techne Corporation, (NASDAQ:TECH) a global provider of tools and reagents for research and diagnostics. Lunaphore’s advanced microfluidic technology enables the analysis of biomarkers in tumors and tissues at single-cell resolution, supporting therapeutic development and improving patient outcomes. “We are […]